Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)
Spain flag Spain · Delayed Price · Currency is EUR
80.50
+0.50 (0.63%)
At close: Mar 18, 2026

BME:ROVI Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
4,1183,2483,2203,2131,9254,138
Market Cap Growth
51.32%0.87%0.22%66.93%-53.49%97.10%
Enterprise Value
4,1523,3333,3403,2231,9024,066
Last Close Price
80.5063.5062.0958.7634.3369.33
PE Ratio
29.3223.1323.5218.869.6427.03
Forward PE
26.2321.5819.0219.7612.7625.70
PS Ratio
5.544.374.223.872.356.38
PB Ratio
6.104.815.545.913.698.79
P/TBV Ratio
6.555.175.986.283.929.42
P/FCF Ratio
33.7926.6540.6854.0410.3037.89
P/OCF Ratio
22.0117.3623.2928.378.1027.69
PEG Ratio
2.272.311.7313.171.420.84
EV/Sales Ratio
5.584.484.373.892.336.27
EV/EBITDA Ratio
20.5617.0516.7313.547.0120.69
EV/EBIT Ratio
23.9719.2518.6914.697.5022.57
EV/FCF Ratio
34.0727.3542.2054.2210.1837.23
Debt / Equity Ratio
0.180.180.200.120.140.16
Debt / EBITDA Ratio
0.600.600.560.270.260.36
Debt / FCF Ratio
1.001.001.451.100.390.67
Net Debt / Equity Ratio
0.030.030.150.07-0.10-0.05
Net Debt / EBITDA Ratio
0.120.120.430.17-0.19-0.13
Net Debt / FCF Ratio
0.190.191.090.67-0.28-0.24
Asset Turnover
0.830.830.940.991.010.99
Inventory Turnover
0.880.880.891.071.101.14
Quick Ratio
1.511.510.990.831.041.35
Current Ratio
3.133.133.132.552.122.66
Return on Equity (ROE)
22.33%22.33%24.33%31.99%40.24%36.24%
Return on Assets (ROA)
12.11%12.11%13.69%16.34%19.68%17.23%
Return on Invested Capital (ROIC)
18.87%19.41%22.00%32.24%43.00%35.96%
Return on Capital Employed (ROCE)
22.40%22.40%26.50%36.60%43.40%33.20%
Earnings Yield
3.41%4.32%4.25%5.30%10.37%3.70%
FCF Yield
2.96%3.75%2.46%1.85%9.71%2.64%
Dividend Yield
1.17%-1.51%1.88%3.77%1.38%
Payout Ratio
34.06%34.06%41.24%40.54%25.55%13.80%
Buyback Yield / Dilution
0.13%0.13%3.73%0.51%3.50%-0.03%
Total Shareholder Return
1.29%0.13%5.23%2.39%7.27%1.35%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.